{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T04:56:56Z","timestamp":1684904216358},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,13]]},"DOI":"10.1097\/qad.0000000000001661","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T19:20:18Z","timestamp":1507922418000},"page":"2431-2433","source":"Crossref","is-referenced-by-count":6,"title":["Potency of HIV-2-specific antibodies increase in direct association with loss of memory B cells"],"prefix":"10.1097","volume":"31","author":[{"given":"Cheila","family":"Rocha","sequence":"first","affiliation":[]},{"given":"Joana","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Borrego","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Calado","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Maria","family":"Marcelino","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Tendeiro","sequence":"additional","affiliation":[]},{"given":"Em\u00edlia","family":"Valadas","sequence":"additional","affiliation":[]},{"given":"Ana Espada","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Taveira","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/imr.12075","article-title":"HIV-1 neutralizing antibodies: understanding nature's pathways","volume":"254","author":"Mascola","year":"2013","journal-title":"Immunol Rev"},{"key":"R2-14-20210130","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1128\/JVI.01482-09","article-title":"Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables","volume":"84","author":"Doria-Rose","year":"2010","journal-title":"J Virol"},{"key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1086\/651144","article-title":"Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression","volume":"201","author":"Euler","year":"2010","journal-title":"J Infect Dis"},{"key":"R4-14-20210130","doi-asserted-by":"crossref","first-page":"e1001251","DOI":"10.1371\/journal.ppat.1001251","article-title":"Characteristics of the earliest cross-neutralizing antibody response to HIV-1","volume":"7","author":"Mikell","year":"2011","journal-title":"PLoS Pathog"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1128\/JVI.00198-11","article-title":"The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection","volume":"85","author":"Gray","year":"2011","journal-title":"J Virol"},{"key":"R6-14-20210130","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/QAD.0b013e32833243e7","article-title":"Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression","volume":"23","author":"van Gils","year":"2009","journal-title":"AIDS"},{"key":"R7-14-20210130","doi-asserted-by":"crossref","first-page":"e1005369","DOI":"10.1371\/journal.ppat.1005369","article-title":"Broadly neutralizing antibody responses in a large longitudinal Sub-Saharan HIV primary infection cohort","volume":"12","author":"Landais","year":"2016","journal-title":"PLoS Pathog"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/JVI.06126-11","article-title":"Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes","volume":"86","author":"de Silva","year":"2012","journal-title":"J Virol"},{"key":"R9-14-20210130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/JVI.06155-11","article-title":"Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection","volume":"86","author":"Kong","year":"2012","journal-title":"J Virol"},{"key":"R10-14-20210130","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1097\/QAD.0b013e328359a89d","article-title":"Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism","volume":"26","author":"Marcelino","year":"2012","journal-title":"AIDS"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/JVI.06315-11","article-title":"Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1","volume":"86","author":"Ozkaya Sahin","year":"2012","journal-title":"J Virol"},{"key":"R12-14-20210130","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1128\/JVI.02789-06","article-title":"Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1) and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections","volume":"81","author":"Rodriguez","year":"2007","journal-title":"J Virol"},{"key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.7915856","article-title":"Reduced rate of disease development after HIV-2 infection as compared to HIV-1","volume":"265","author":"Marlink","year":"1994","journal-title":"Science"},{"key":"R14-14-20210130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/QAD.0b013e3282f4ddfc","article-title":"Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France","volume":"22","author":"Drylewicz","year":"2008","journal-title":"AIDS"},{"key":"R15-14-20210130","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/QAD.0b013e3283568849","article-title":"Memory B-cell depletion is a feature of HIV-2 infection even in the absence of detectable viremia","volume":"26","author":"Tendeiro","year":"2012","journal-title":"AIDS"},{"key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<111::AID-JMV18>3.0.CO;2-W","article-title":"Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load","volume":"61","author":"Soriano","year":"2000","journal-title":"J Med Virol"},{"key":"R17-14-20210130","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1128\/JVI.01921-10","article-title":"Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients","volume":"85","author":"Soares","year":"2011","journal-title":"J Virol"},{"key":"R18-14-20210130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1742-4690-5-78","article-title":"The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients","volume":"5","author":"Borrego","year":"2008","journal-title":"Retrovirology"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3851\/IMP1996","article-title":"Baseline susceptibility of primary HIV-2 to entry inhibitors","volume":"17","author":"Borrego","year":"2012","journal-title":"Antivir Ther"},{"key":"R20-14-20210130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1742-4690-10-110","article-title":"Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response","volume":"10","author":"Rocha","year":"2013","journal-title":"Retrovirology"},{"key":"R21-14-20210130","doi-asserted-by":"crossref","first-page":"12429","DOI":"10.1128\/JVI.01102-10","article-title":"Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy","volume":"84","author":"Marcelino","year":"2010","journal-title":"J Virol"},{"key":"R22-14-20210130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JCM.44.2.607-611.2006","article-title":"Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins","volume":"44","author":"Marcelino","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R23-14-20210130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/blood-2016-01-694356","article-title":"Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy","volume":"128","author":"Bhoj","year":"2016","journal-title":"Blood"},{"key":"R24-14-20210130","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.169.6.3400","article-title":"CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load","volume":"169","author":"Sousa","year":"2002","journal-title":"J Immunol"},{"key":"R25-14-20210130","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1128\/JVI.74.20.9594-9600.2000","article-title":"Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1","volume":"74","author":"Schramm","year":"2000","journal-title":"J Virol"},{"key":"R26-14-20210130","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1046\/j.1365-2249.1999.00914.x","article-title":"Proviral load and immune function in blood and lymph node during HIV-1 and HIV-2 infection","volume":"116","author":"Jobe","year":"1999","journal-title":"Clin Exp Immunol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0000000000001661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:19:57Z","timestamp":1620969597000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201711130-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,13]]},"references-count":26,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0000000000001661","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11,13]]}}}